CHELSEA VAN ROOY: Open Payments
NPI 1548796493 · PRESTONSBURG, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$204 in 11 payments from 9 companies in 2025. Trend: 2023 $219 · 2024 $241 · 2025 $204
Food & beverage: $204
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
| Lilly USA, LLC | 2 | $30 |
| ABBVIE INC. | 1 | $29 |
| Stryker Corporation | 1 | $28 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| KYOWA KIRIN, INC. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
| Novo Nordisk Inc | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
Products named: JARDIANCE, VRAYLAR, CLOTTRIEVER BOLD CATHETER, FANAPT, CRYSVITA, Kerendia, Ozempic, VOQUEZNA.
Industry payments across KY — which companies pay providers there.
